CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
1402-87-5 | | argomycin | | | | |
1402-88-6 | | ascosin | | | | |
1402-99-9 | | bacitracin b | | | | |
140200-76-6 | 1,5-二溴-3-酮 | 1,5-dibromopentan-3-one | C5H8Br2O | 243.92 | 89.7-90.5 °C | 259.1±25.0 °C(Predicted) |
1402002-76-9 | | pf-06442609 | | | | |
1402003-94-4 | | 4-fluoro-7-methoxybenzo[d]thiazol-2-amine | | | | |
1402004-07-2 | 6-甲氧基-5-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)吡啶甲酸甲酯 | methyl 6-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | | | | |
1402004-77-6 | | 1-chloro-2-fluoro-3-iodo-4-methoxybenzene | | | | |
140204-23-5 | | formaldehyde, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, 4-(1,1-dimet | | | | |
1402045-48-0 | N-(2-ethoxy-5-methylphenyl)acetamide | | C11H15NO2 | 193.246 | | |
1402047-77-1 | | tert-butyl 4-amino-4-(trifluoromethyl)piperidine-1-carboxylate hydrochloride | C11H20ClF3N2O2 | 304.74 | | |
1402057-86-6 | 5-((1H-吡咯并[2,3-b]吡啶-3-基)亚甲基)-2-(7-甲氧基-3,4-二氢异喹啉-2(1H)-基)-4-氧代-4,5-二氢呋喃-3-羧酸乙酯 | Ethyl 5-((1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-2-(7-methoxy-3,4-dihydroisoquinolin-2(1H)-yl)-4-oxo-4,5-dihydrofuran-3-carboxylate | C25H23N3O5 | 445.47 | | |
1402057-88-8 | AS-0141 | | C21H22F3N5O4 | 465.43 | | |
1402059-17-9 | Cdc7-IN-7 | | C21H22N4O5 | 410.42 | | |
140207-93-8 | | 4-o-methyl-alpha-d-glucurono-beta-d-xylan, hydrogen sulfate, sodium salt | | | | |
1402072-31-4 | (2R,3R,4R,5R)-2-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)-5-(2-(2-(4-异丙基苯氧基)乙酰胺基)-6-氧代-3,6-二氢-9H-嘌呤-9-基)-4-甲氧基四氢呋喃-3-基(2-氰乙基)二异丙基亚磷酰胺 | (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(2-(4-isopropylphenoxy)acetamido)-6-oxo-3,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite | C52H62N7O10P | 976.06 | | |
1402072-52-9 | 3-(5-甲氧基-1H-吲哚-3-基)败脂酸 | | C12H11NO3 | 217.22 | | |
140208-23-7 | 血纤维蛋白溶酶原激活物抑制剂1(pai-1) 人 | plasminogen activator inhibitor 1 (pai-1) human | | | | |
1402086-20-7 | Afatinib impurity 11 | | C21H18ClFN4O3 | 428.84 | | |
14021-93-3 | | 4-dimethylamino-decane-2,9-diol | C12H27NO2 | 217.35 | | |
140211-06-9 | rel-苄基(4ar,7as)-7-氧代八氢-2h-环戊二烯并[c]吡啶-2-羧酸酯 | rel-benzyl (4ar,7as)-7-oxooctahydro-2h-cyclopenta[c]pyridine-2-carboxylate | | | | |
140211-07-0 | 苄基(4as,7as)-7-氧代-八氢-1h-环戊二烯并[c]吡啶-2-羧酸酯 | benzyl (4as,7as)-7-oxo-octahydro-1h-cyclopenta[c]pyridine-2-carboxylate | C16H19NO3 | 273.332 | | |
140212-86-8 | | azacycloeicosa-3,5,7,11,13,15,17-heptaen-2-one, 9,10-dihydroxy-7,15-dimethyl-20 | | | | |
140213-08-7 | | 3-(2,6-dioxopiperidin-1-yl)benzoic acid | | | | |
1402132-40-4 | 4-己基-5-(4,4,5,5-四甲基-1,3,2-二氧戊环-2-基)噻吩-2-甲醛 | 4-hexyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbaldehyde | C17H27BO3S | 322.27 | | |
1402142-62-4 | 地瑞那韦杂质16 | darunavir impurity 16 | | | | |
1402146-02-4 | 镍(II) meso-二均三甲苯基去甲咔咯 | Ni(II) meso-Dimesitylnorcorrole | C36H30N4Ni | 577.36 | | |
1402148-68-8 | 4-氨基-4-(丙烷-2-基)哌啶-1-羧酸叔丁酯 | tert-butyl 4-amino-4-(propan-2-yl)piperidine-1-carboxylate | C13H26N2O2 | 242.3577 | | 312.1±35.0 °C(Predicted) |
1402149-98-7 | 2-(((3ar,4S,6R,6as)-6-氨基-2,2-二甲基四氢-3ah-环戊二烯并[d][1,3]二氧杂环戊烯-4-基)氧基)乙酸酯草酸盐 | ethyl 2-(((3ar,4S,6R,6as)-6-amino-2,2-dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate oxalate | C14H23NO9 | 349.33 | | |
140215-42-5 | 2-(3-(溴甲基)苯基)乙酸乙酯 | Ethyl 2-(3-(bromomethyl)phenyl)acetate | C11H13BrO2 | 257.12 | | |
1402150-32-6 | 替卡格雷杂质10 | ticagrelor impurity 10 | C14H23ClN4O4S | 378.87 | | |
1402158-49-9 | 3-(4-溴苯基)氧杂环丁烷 | 3-(4-bromophenyl)oxetane | C9H9BrO | 213.0712 | | |
1402165-97-2 | 5-(5-pyrimidyl)thiophene-2-boronic acid pinacol ester | | C14H19BN2O3S | 306.18826 | | |
1402165-98-3 | 4-(5-pyrimidyl)thiophene-2-boronic acid pinacol ester | | C14H19BN2O3S | 306.18826 | | |
1402166-32-8 | 2-溴-5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)噻唑 | 2-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole | C9H13BBrNO2S | 289.99 | | 341.0±15.0 °C(Predicted) |
1402166-51-1 | 4-(3-Thienyl)thiophene-2-boronic acid pinacol ester | | C14H19BO3S2 | 310.23986 | | |
1402166-52-2 | 4-(2-Thienyl)thiophene-2-boronic acid pinacol ester | | C14H19BO3S2 | 310.23986 | | |
1402166-53-3 | 5-(3-Thienyl)thiophene-2-boronic acid pinacol ester | | C14H19BO3S2 | 310.23986 | | |
1402166-55-5 | 2-(5-cyclohexylthiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | | C16H25BO2S | 292.2445 | | |
1402166-63-5 | N-(2-Acetoxyethyl)-2-methylimidazole-4-boronic acid pinacol ester | | C14H25BN2O5 | 312.1697 | | |
1402166-69-1 | 2-(哌啶-1-基)-5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)噻唑 | 2-(Piperidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole | C14H23BN2O2S | 294.22 | | 415.4±37.0 °C(Predicted) |
1402166-71-5 | 2-(4-(4, 4, 5, 5-四甲基-1, 3, 2-二氧硼杂环戊烷-2-基)-1H-吡唑-1-基)苯甲腈 | 2-(4-(4, 4, 5, 5-Tetramethyl-1, 3, 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile | C16H18BN3O2 | 295.14 | | |
1402166-72-6 | 4-(4-(4, 4, 5, 5-四甲基-1, 3, 2-二氧硼杂环戊烷-2-基)-1H-吡唑-1-基)苯甲腈 | 4-(4-(4, 4, 5, 5-Tetramethyl-1, 3, 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile | C16H18BN3O2 | 295.14 | | |
140217-83-0 | 6-羟基-1,4-硫氮杂环庚烷-4-羧酸叔丁酯 1,1-二氧化物 | Tert-Butyl 6-hydroxy-1,4-thiazepane-4-carboxylate 1,1-dioxide | C10H19NO5S | 265.33 | | |
1402172-49-9 | 4-(5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)噻唑-2-基)吗啉 | 4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)morpholine | C13H21BN2O3S | 296.19 | | 428.6±55.0 °C(Predicted) |
1402173-84-5 | 5-(3-Tolyl)thiophene-2-boronic acid pinacol ester | | C17H23BO3S | 318.23872 | | |
1402174-21-3 | 2-(4-甲基-1-哌啶基)-5-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)嘧啶 | 2-(4-Methylpiperidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | C16H26BN3O2 | 303.21 | | |
1402174-29-1 | 5-(4-Fluorophenyl)thiophene-2-boronic acid pinacol ester | | C16H20BFO3S | 322.2026032 | | |
1402174-30-4 | 5-(3-Fluorophenyl)thiophene-2-boronic acid pinacol ester | | C16H20BFO3S | 322.2026032 | | |
1402174-37-1 | 1-(4-氯苯基)-4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)-1H-吡唑 | 1-(4-Chlorophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | C15H18BClN2O2 | 304.58 | | 412.3±25.0 °C(Predicted) |